NCT03811600View on ClinicalTrials.gov

Exosomes Implication in PD1-PD-L1 Activation in OSAS

CompletedOBSERVATIONAL
Enrollment

90

Participants

Timeline

Start Date

March 3, 2019

Primary Completion Date

October 14, 2020

Study Completion Date

October 14, 2020

Conditions
Sleep Apnea Syndromes, ObstructiveCancer
Interventions
DIAGNOSTIC_TEST

PD1/PD-L1 exosomal expression

exosomal PD1/PD-L1 expression

Trial Locations (1)

49100

Laboratoire du Sommeil, Département de Pneumologie, CHU d'Angers, Angers

All Listed Sponsors
lead

University Hospital, Angers

OTHER_GOV

NCT03811600 - Exosomes Implication in PD1-PD-L1 Activation in OSAS | Biotech Hunter | Biotech Hunter